These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 4149420

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of chronic heat exposure on drug metabolism in the rat.
    Ben Zvi Z, Kaplanski J.
    J Pharm Pharmacol; 1980 May; 32(5):368-9. PubMed ID: 6104708
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
    van Peer AP, Belpaire FM, Bogaert MG.
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):346-7. PubMed ID: 708161
    [No Abstract] [Full Text] [Related]

  • 25. Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation and in vivo.
    Rowland M.
    Eur J Pharmacol; 1972 Mar; 17(3):352-6. PubMed ID: 5022150
    [No Abstract] [Full Text] [Related]

  • 26. Practical pharmacokinetic techniques for drug consultation and evaluation. 3. Psychotherapeutic drugs as prototypes for illustrating some considerations in pharmacist-generated dosage regimens.
    Schumacher GE, Weiner J.
    Am J Hosp Pharm; 1974 Jan; 31(1):59-66. PubMed ID: 4810166
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
    Greenblatt DJ, Divoll M, Abernethy DR, Harmatz JS, Shader RI.
    J Pharmacol Exp Ther; 1982 Jan; 220(1):120-6. PubMed ID: 7053408
    [No Abstract] [Full Text] [Related]

  • 31. A comparative study of drug metabolism in the isolated perfused liver and in vivo in rats.
    von Bahr C, Alexanderson B, Azarnoff DL, Sjoqvist F, Orrenius S.
    Eur J Pharmacol; 1970 Jan; 9(1):99-105. PubMed ID: 5434299
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Analysis of the relation between pharmacokinetic processes and pharmacological effects in humans].
    Dorokhov VV, Kholodov LE.
    Farmakol Toksikol; 1985 Jan; 48(5):119-25. PubMed ID: 3908140
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Interindividual variations in drug disposition. Clinical implications and methods of investigation.
    Breimer DD.
    Clin Pharmacokinet; 1983 Jan; 8(5):371-7. PubMed ID: 6627809
    [No Abstract] [Full Text] [Related]

  • 36. Induction of drug metabolism. VII. Differences in P-420 hemoproteins from untreated and 3-methylcholanthrene-treated rats.
    Shoeman DW, Vane FM, Mannering GJ.
    Mol Pharmacol; 1973 May; 9(3):373-82. PubMed ID: 4710137
    [No Abstract] [Full Text] [Related]

  • 37. Dose-dependent pharmacokinetics: emphasis on phase I metabolism.
    Dayton PG, Sanders JE.
    Drug Metab Rev; 1983 May; 14(3):347-405. PubMed ID: 6347591
    [No Abstract] [Full Text] [Related]

  • 38. Ascorbic acid and drug metabolism in cynomologus monkeys.
    Green M, Turnbull J, Sauberlich H, Omaye S.
    Proc West Pharmacol Soc; 1978 May; 21():341-4. PubMed ID: 99749
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
    Eichelbaum M.
    Internist (Berl); 1983 Mar; 24(3):117-27. PubMed ID: 6135670
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.